VSTM - Verastem, Inc.

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
9.0 0.41 (4.56%)	---	---	---	-0.01 (-0.11%)	0.45 (5.03%)	0.0 (0.0%)	0.0 (0.0%)

Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: AfterHours

Earnings & Ratios

Basic EPS:: -0.39
Diluted EPS:: -0.62
Basic P/E:: -24.1282
Diluted P/E:: -15.1774
RSI(14) 1m:: 100.0
VWAP:: 9.41
RVol:: 1.0837

Events

Period	Kind	Movement	Occurred At
1m	Price increase 1m	9.25 +0.16 (+1.76%)	Oct 15 09:33
10m	Price increase 10m	9.25 +0.3 (+3.35%)	Oct 15 09:33
1m	Price increase 1m	9.05 +0.1 (+1.06%)	Oct 15 09:30